ALXN
Jennison Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-21,575
| Closed | -$3.3M | – | 739 |
|
2021
Q1 | $3.3M | Hold |
21,575
| – | – | ﹤0.01% | 501 |
|
2020
Q4 | $3.37M | Buy |
+21,575
| New | +$3.37M | ﹤0.01% | 470 |
|
2020
Q3 | – | Sell |
-33,182
| Closed | -$3.72M | – | 707 |
|
2020
Q2 | $3.72M | Sell |
33,182
-326,536
| -91% | -$36.6M | ﹤0.01% | 440 |
|
2020
Q1 | $32.3M | Sell |
359,718
-1,503,312
| -81% | -$135M | 0.04% | 191 |
|
2019
Q4 | $201M | Sell |
1,863,030
-181,059
| -9% | -$19.6M | 0.2% | 66 |
|
2019
Q3 | $200M | Sell |
2,044,089
-6,969,813
| -77% | -$683M | 0.21% | 60 |
|
2019
Q2 | $1.18B | Sell |
9,013,902
-1,227,555
| -12% | -$161M | 1.17% | 25 |
|
2019
Q1 | $1.38B | Buy |
10,241,457
+1,512,545
| +17% | +$204M | 1.37% | 23 |
|
2018
Q4 | $850M | Buy |
8,728,912
+101,376
| +1% | +$9.87M | 0.95% | 31 |
|
2018
Q3 | $1.2B | Buy |
8,627,536
+2,599,414
| +43% | +$361M | 1.1% | 26 |
|
2018
Q2 | $748M | Sell |
6,028,122
-1,459,471
| -19% | -$181M | 0.73% | 41 |
|
2018
Q1 | $835M | Buy |
7,487,593
+2,466,428
| +49% | +$275M | 0.83% | 41 |
|
2017
Q4 | $600M | Sell |
5,021,165
-311,471
| -6% | -$37.2M | 0.59% | 46 |
|
2017
Q3 | $748M | Buy |
5,332,636
+4,682,336
| +720% | +$657M | 0.77% | 37 |
|
2017
Q2 | $79.1M | Sell |
650,300
-8,976,179
| -93% | -$1.09B | 0.08% | 198 |
|
2017
Q1 | $1.17B | Buy |
9,626,479
+1,350,652
| +16% | +$164M | 1.25% | 21 |
|
2016
Q4 | $1.01B | Buy |
8,275,827
+1,138,592
| +16% | +$139M | 1.13% | 25 |
|
2016
Q3 | $875M | Buy |
7,137,235
+43,840
| +0.6% | +$5.37M | 0.94% | 31 |
|
2016
Q2 | $828M | Sell |
7,093,395
-216,732
| -3% | -$25.3M | 0.91% | 32 |
|
2016
Q1 | $1.02B | Sell |
7,310,127
-35,897
| -0.5% | -$5M | 1.07% | 27 |
|
2015
Q4 | $1.4B | Buy |
7,346,024
+481,031
| +7% | +$91.8M | 1.38% | 18 |
|
2015
Q3 | $1.07B | Buy |
6,864,993
+913,030
| +15% | +$143M | 1.1% | 23 |
|
2015
Q2 | $1.08B | Buy |
5,951,963
+711,725
| +14% | +$129M | 0.99% | 26 |
|
2015
Q1 | $908M | Sell |
5,240,238
-553,113
| -10% | -$95.9M | 0.83% | 33 |
|
2014
Q4 | $1.07B | Sell |
5,793,351
-2,589,663
| -31% | -$479M | 1% | 26 |
|
2014
Q3 | $1.39B | Buy |
8,383,014
+234,768
| +3% | +$38.9M | 1.29% | 12 |
|
2014
Q2 | $1.27B | Sell |
8,148,246
-232,924
| -3% | -$36.4M | 1.17% | 15 |
|
2014
Q1 | $1.28B | Sell |
8,381,170
-16,719
| -0.2% | -$2.54M | 1.22% | 14 |
|
2013
Q4 | $1.12B | Sell |
8,397,889
-237,117
| -3% | -$31.6M | 1.1% | 20 |
|
2013
Q3 | $1B | Sell |
8,635,006
-1,023,542
| -11% | -$119M | 1.05% | 20 |
|
2013
Q2 | $891M | Buy |
+9,658,548
| New | +$891M | 1% | 26 |
|